These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 3404769
1. Muscarinic receptor-mediated inhibition of dopaminergic excitatory input to caudate neurons from the substantia nigra. Nabatame H, Sasa M, Takaori S, Kameyama M. Jpn J Pharmacol; 1988 Apr; 46(4):387-95. PubMed ID: 3404769 [Abstract] [Full Text] [Related]
4. Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation. Todo N, Momiyama T, Amano T, Kohno Y, Sasa M. Life Sci; 1994 Apr; 54(14):957-66. PubMed ID: 7908115 [Abstract] [Full Text] [Related]
5. Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation. Ohno Y, Sasa M, Takaori S. Life Sci; 1986 May 19; 38(20):1867-73. PubMed ID: 2939313 [Abstract] [Full Text] [Related]
7. Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392). Sasa M, Ohno Y, Takaori S. Life Sci; 1988 May 19; 43(3):263-9. PubMed ID: 3398698 [Abstract] [Full Text] [Related]
8. Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra. Matsubayashi H, Amano T, Sasa M. Psychopharmacology (Berl); 1999 Sep 19; 146(2):139-43. PubMed ID: 10525748 [Abstract] [Full Text] [Related]
9. Changes in multiunit activity of nigral neurons induced by cholinergic and dopaminergic stimulation of the caudate nucleus. Pazo JH, Medina JH. Brain Res; 1982 Oct 14; 249(2):301-8. PubMed ID: 6291714 [Abstract] [Full Text] [Related]
10. Dopaminergic inhibition from substantia nigra of caudate neurons activated by cortical stimulation. Fujimoto S, Sasa M, Takaori S. Jpn J Pharmacol; 1981 Dec 14; 31(6):1037-42. PubMed ID: 7334727 [Abstract] [Full Text] [Related]
11. Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area. Sasa M, Hara M, Takaori S. Prog Neuropsychopharmacol Biol Psychiatry; 1991 Dec 14; 15(1):119-28. PubMed ID: 1826178 [Abstract] [Full Text] [Related]
12. Ventral tegmental area-mediated inhibition of neurons of the nucleus accumbens receiving input from the parafascicular nucleus of the thalamus is mediated by dopamine D1 receptors. Hara M, Sasa M, Takaori S. Neuropharmacology; 1989 Nov 14; 28(11):1203-9. PubMed ID: 2687713 [Abstract] [Full Text] [Related]
14. Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons. Matsubayashi H, Amano T, Hongjing Y, Kohno Y, Sasa M. Psychopharmacology (Berl); 1995 Aug 14; 120(4):369-75. PubMed ID: 8539316 [Abstract] [Full Text] [Related]
15. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents. Adachi K, Hasegawa M, Fujita S, Sato M, Miwa Y, Ikeda H, Koshikawa N, Cools AR. Eur J Pharmacol; 2002 May 03; 442(1-2):81-92. PubMed ID: 12020685 [Abstract] [Full Text] [Related]
16. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction. Shen RY, Asdourian D, Chiodo LA. Synapse; 1992 Aug 03; 11(4):319-29. PubMed ID: 1354398 [Abstract] [Full Text] [Related]
17. Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area. Momiyama T, Sasa M, Takaori S. Life Sci; 1991 Aug 03; 49(7):535-43. PubMed ID: 1677740 [Abstract] [Full Text] [Related]
18. Cholinergic and GABAergic modulation of self-stimulation of lateral hypothalamus and ventral tegmentum: effects of carbachol, atropine, bicuculline, and picrotoxin. Singh J, Desiraju T, Raju TR. Physiol Behav; 1997 Mar 03; 61(3):411-8. PubMed ID: 9089760 [Abstract] [Full Text] [Related]
19. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons. Di Loreto S, Florio T, Scarnati E. Exp Brain Res; 1992 Mar 03; 89(1):79-86. PubMed ID: 1351000 [Abstract] [Full Text] [Related]
20. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Gronier B, Debonnel G. Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]